Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy
Oncogene-induced STAT3-activation is central to tumor progression by promoting cancer cell expression of pro-angiogenic and immunosuppressive factors. STAT3 is also activated in infiltrating immune cells including tumor-associated macrophages (TAM) amplifying immune suppression. Consequently, STAT3...
Main Authors: | Grégory Verdeil, Toby Lawrence, Anne-Marie Schmitt-Verhulst, Nathalie Auphan-Anezin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/12/1832 |
Similar Items
-
Regulatory Networks Involving STATs, IRFs, and NFκB in Inflammation
by: Ekaterini Platanitis, et al.
Published: (2018-11-01) -
Modulation of STAT-1, STAT-3, and STAT-6 activities in THP-1 derived macrophages infected with two Trypanosoma cruzi strains
by: Melissa Martins Oliveira, et al.
Published: (2022-10-01) -
Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication
by: Chin-Yap Loh, et al.
Published: (2019-02-01) -
STAT1 inhibits STAT3 activation in esophageal squamous cell carcinoma
by: Liu Z, et al.
Published: (2018-11-01) -
GM-CSF-activated STAT5A regulates macrophage functions and inflammation in atherosclerosis
by: Jan Nagenborg, et al.
Published: (2023-10-01)